A clinical trial has found that a prescription form of the omega-3 fatty acid eicosapentaenoic acid (EPA) was associated with longer overall survival among patients undergoing surgery for colorectal ...

Agenus ( AGEN) reported that 72% of patients with locally advanced colon cancer had no detectable cancer remaining at surgery ...

A new study finds metastatic colorectal cancer's immune defenses may begin outside the cancer cell, challenging view held for ...

At the ESMO Congress 2026, Xencor Inc. XNCR shared updated results from the Phase 1 study of XmAb819 for advanced clear cell ...

Curcumae Rhizoma herb pair synergistically enhances 5-fluorouracil against colorectal cancer by disrupting DNA repair and ...

For decades, the standard of care for patients with resected stage II and III colon cancer has centred on surgery with consideration of postoperative adjuvant systemic therapy to reduce risk of ...

New research shows how colon cancer survivors can overcome mental hurdles to stick with long-term exercise—a shift in mindset ...

But laparoscopic liver resection was associated with lower 30-day morbidity compared with open liver resection.

VASCEPA was associated with an increased risk (3% vs 2%) of atrial fibrillation or atrial flutter requiring hospitalization ...

Incyte's INCB161734 KRAS G12D inhibitor posted 89% and 81% objective response rates in Phase I PDAC and CRC data at ESMO 2026 ...

Genmab A/S (Nasdaq: GMAB) today announced updated follow-up analyses from a Phase 2 trial evaluating petosemtamab, an ...

Between 2011 and 2022, patients from the most disadvantaged neighborhoods in Kentucky and Georgia who were diagnosed with ...